New Delhi: The controversy over the decision to ban the use of Malayalam language continued to escalate. Now that the controversy is seen to be escalating, the administration has withdrawn its order. GB Pant Hospital had instructed not to use Malayalam language at work. Rahul Gandhi and Shashi Tharoor had objected after knowing the order. In such a situation, these orders have now been withdrawn. The controversial circular of GB Pant Hospital in Delhi had raised a big question about the way nurses worked. In the circular issued here, all nurses were asked to speak in Hindi or English language. Not only that, the circular said that apart from these two languages, if spoken in any other language, action would be taken against them.

As soon as the circular came to light, objections started to be raised. Congress MP Rahul Gandhi objected to this and said, "Malayalam is as Indian language as any other language. Discrimination in the name of languages should be stopped." On the other hand, shashi tharoor tweeted: "It is surprising that in a democratic country like India, a government institution can ask its nurses not to speak in their mother tongue to those who can understand them. This is absolutely unacceptable."

What was the matter: Yes, in fact, the hospital administration had received a complaint that nursing staff speak in their state and local language, causing inconvenience to the patients. Following the complaint, GB Pant Hospital issued the circular and said that there have been complaints that Malayalam language is being used instead of working. In addition, it was said that most people do not understand it, which creates a state of helplessness and inconvenience. Due to this, all nursing staff have been instructed to use Hindi and English language for talks, otherwise strict action will be taken.

Congress built 160 luxurious houses in Rajasthan worth of Rs 266 crore: Hardeep Singh Puri

Centre's dangerous vaccination policy: Congress leader Adhir Ranjan Chowdhury

Hardeep Singh Puri accuses Congress of selling vaccine at higher rate